S
GPCR
Structure Therapeutics Inc ADR
41.45
+0.09+0.21%After Hours: 46.99 +5.54 +13.36%19:59 04/30 EDT
OPEN/PREV CLOSE43.16/43.04
TODAY RANGE42.16-44.78
VOL167.06K
MARKET CAP3.00B
52 WEEK RANGE15.80-94.90
AVG VOL (3M)950.43K
% TURNOVER0.24%
TURNOVER--
P/E (TTM)-17.7008
% RANGE6.09%
EPS(TTM)-2.3852
P/E(FORWARD)-25.0564
P/B1.972
BVPS21.41
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.86B
SHARES OUTSTANDING71.07M
NEXT EARNINGS05/06-05/11
FREE FLOAT67.73M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·04/27 13:08
Structure Therapeutics Price Target Announced at $101.00/Share by Canaccord Genuity
TipRanks·04/27 12:58
Canaccord starts Structure Therapeutics on oral weight loss pipeline
TipRanks·04/27 10:00
Structure Therapeutics initiated with a Buy at Canaccord
TipRanks·04/15 10:43
Structure Therapeutics Appoints Matthew Lang as Chief Operating Officer
Seeking Alpha·04/14 20:13
Structure Therapeutics appoints Matthew Lang as chief operating officer
Benzinga·04/14 20:09
Structure Therapeutics Appoints Matthew Lang COO
PUBT·04/14 20:05
Structure Therapeutics names Matthew Lang COO, general counsel
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.